Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Barking: Drug companies resort to double-blind placebo boys in suits with violin cases
About the author: 
WDDTY Team

Is UK Prime Minister Tony Blair still US President Bush's poodle? We'll soon find out following intensive lobbying by the White House to grant the American pharmaceutical giants unrestricted access to the UK market

Is UK Prime Minister Tony Blair still US President Bush's poodle? We'll soon find out following intensive lobbying by the White House to grant the American pharmaceutical giants unrestricted access to the UK market.

That means every new, approved drug would become immediately available on the UK's National Health Service as part of a free market initiative.

And the American system of advertising drugs directly to the patient would also be introduced, US deputy health secretary Alex Azar has mooted.

These radical suggestions are an attempt to circumvent Nice (National Institute for Clinical Excellence), the gatekeeper of the NHS that determines which drug should be prescribed on the NHS, based on an evaluation of efficacy and cost.

Nice has been upsetting quite a few drug companies of late, and has blocked many an 'innovative' drug, either because it doesn't work or because it costs too much.

Things reached a head recently when drug company representatives met with UK government officials to complain about Nice.

Pfizer said it might withdraw its investment in the UK if Nice continued to block its Alzheimer's drug, and Bristol-Myers Squibb said it wanted to invest in countries that had a "favourable environment".

Now, we know medicine tries to maintain the pretence that it is a science, but we suppose it has finally abandoned that charade when it threatens to send the boys round.

(Source: The Guardian, 14 November 2006, and 28 September 2006).

E-news broadcast 16 November 2006 No.310 [Subscribe]


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved